ArticleAMB Express2017
Screening of filamentous fungi for antimicrobial silver nanoparticles synthesis.
Article in AMB Express, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed.
- Effective bio-activities of the metal nanoparticles mycosynthesized by the plants' fungal endophytes.Microbial cell factories · 2026Review
- Antimicrobial potential of silver nanoparticles synthesized from mushroom extracts against drug-resistant pathogens.New microbes and new infections · 2026Article
- Biosynthesis of silver nanoparticles by Talaromyces funiculosus for therapeutic applications and safety evaluation.Scientific reports · 2025Article
- Ecotoxicity of fungal-synthesized silver nanoparticles: mechanisms, impacts, and sustainable mitigation strategies.3 Biotech · 2025Review
- Harnessing the power of Neobacillus niacini AUMC-B524 for silver oxide nanoparticle synthesis: optimization, characterization, and bioactivity exploration.Microbial cell factories · 2024Article
- A review on mycogenic metallic nanoparticles and their potential role as antioxidant, antibiofilm and quorum quenching agents.Heliyon · 2024Review
- The Synergistic Effect of Biosynthesized Silver Nanoparticles and Phytocompound as a Novel Approach to the Elimination of Pathogens.Molecules (Basel, Switzerland) · 2023Article
- The Potential ofNanomaterials (Basel, Switzerland) · 2023Review
- Diversity of Biogenic Nanoparticles Obtained by the Fungi-Mediated Synthesis: A Review.Biomimetics (Basel, Switzerland) · 2022Review
- The biofabrication of ZnO nanoparticles using the green soft technique reduction of Zincum Gluconicum (ZNG) by extracellular mycofiltrate ofJournal of medicine and life · 2022Article
- Mycosynthesis of Metal-Containing Nanoparticles-Fungal Metal Resistance and Mechanisms of Synthesis.International journal of molecular sciences · 2022Review
- Antibacterial activity of biosynthesized silver nanoparticles (AgNps) against Pectobacterium carotovorum.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022Article
- Microbial silver resistance mechanisms: recent developments.World journal of microbiology & biotechnology · 2022Review
- Physiological Response ofJournal of fungi (Basel, Switzerland) · 2022Article
- Rapid Enzymatically Reduction of Zincum Gluconicum for the Biomanufacturing of Zinc Oxide Nanoparticles by Mycoextracellular Filtrate ofArchives of Razi Institute · 2022Article
- A combined treatment of Proteinase K and biosynthesized ZnO-NPs for eradication of dairy biofilm of sporeformers.AIMS microbiology · 2022Article
- Mycology-Nanotechnology Interface: Applications in Medicine and Cosmetology.International journal of nanomedicine · 2022Review
- Soil Fungi as Biomediator in Silver Nanoparticles Formation and Antimicrobial Efficacy.International journal of nanomedicine · 2022Article
- Biologically formed silver nanoparticles andIranian journal of microbiology · 2021Article
- Interactive Effects of Biosynthesized Nanocomposites and Their Antimicrobial and Cytotoxic Potentials.Nanomaterials (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present work had the goal of screening a batch of 20 fungal strains, isolated from sugar cane plantation soil, in order to identify those capable of biosynthesis of silver nanoparticles. These nanoparticles are known to have a large and effective application in clinical microbiology. Four strains were found to be capable of biosynthesis of silver nanoparticles. The biosynthesised nanoparticles were characterised by UV-vis spectroscopy, scanning electron microscopy, EDX, and XRD. They were found to have an average size of 30-100 nm, a regular round shape, and potential antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The antimicrobial activity was found to be directly related to the nanoparticles concentration. Mycogenic synthesis of nanoparticles is a green biogenic process preferable to other alternatives. Because fungi are great producers of extracellular enzymes this process makes scaling-up an easier task with high importance for clinical microbiology on the fight against microbial resistance, as well as for other industrial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.